Cell and gene therapies (CGT) are a promising approach to combat previously untreatable diseases. Although the principle to enhance the body’s immune system appears obvious, successful CGT development is a demanding and lengthy process.

In this virtual symposium Miltenyi Biotec researchers and customers share their experiences along the CAR T cell and CAR NK cell development and manufacturing path. Scientists and clinicians will get an insight into how cutting edge technologies, like high-content and 3D imaging, electroporation, and validated express flow cytometry analyses help overcome challenges in CGT development.

Attend this event to learn:

• Apply imaging in target validation
• Learn about new technologies in CGT
• Upgrade IPC/QC & patient monitoring